Treatment of venous thromboembolism in Northern Italy: A population-based study from 2013 to 2018. Issue 188 (April 2020) - Baviera, Marta
Highlights: NOACs gradually replaced VKA use for VTE treatment. Rivaroxaban and apixaban were the most prescribed drugs among the NOACs. Recurrent VTE and intracranial bleeding were lower in the NOAC than VKA group. NOACs showed a favorable benefit-risk offering an alternative to VKAs.